Institution
Eckert & Ziegler (United States)
UScompany
Recent research
- BiologyOpen access
A Nontoxin Aminopyrimidine Probe for Near State-Independent NaV1.7 Inhibition
Abstract The voltage-gated sodium channel NaV1.7 is among the most compelling genetically validated pain targets; however, advanced small-molecule inhibitors, including voltage-sensing domain IV (VSD4)-directed series, have not yet achieved robust clinical efficacy, potentially r...
- Health & Medicine
Introduction: Outcomes among the Hispanic population are rarely explored in adolescents and young adults (AYAs). We aimed to compare sociodemographic, clinical, and survival outcomes of Latin American AYAs (≤39 years) with middle-aged (40–59 years) and older (≥60 years) patients...